Skip to main content
SpringerLink
Log in

Aflibercept/bevacizumab/ranibizumab

Cataract: 6 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Carrola G, et al. Inflammatory Choroidal Neovascular Membranes: Clinical Profile, Treatment Effectiveness, and Visual Prognosis. Journal of Ophthalmology 2021: 23 Jul 2021. Available from: URL: http://www.hindawi.com/journals/jop/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aflibercept/bevacizumab/ranibizumab. Reactions Weekly 1887, 30 (2022). https://doi.org/10.1007/s40278-022-07695-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-07695-1

Search

Navigation